SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Sudarshan Pharmaceuticals Shares Rise 7% After NSE Listing

Sudarshan Pharmaceuticals shares ended 7% higher on Wednesday. The stock has gained close to 25.37% in six months and around 60% in one year; the recent uptick followed its formal listing on the National Stock Exchange.

SUDARSHAN

New Delhi, Oct. 28 -- Shares of Sudarshan Pharmaceuticals rallied to end 7% higher on Wednesday. The stock has delivered close to 25.37% return in six months and around 60% surge in one year. The recent uptick in stock movement has come after the pharma stock's formal listing on National Stock Exch…